Document Detail


Effects of smoking on visual acuity of central serous chorioretinopathy patients.
MedLine Citation:
PMID:  23841829     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Background: The aim of this study was to evaluate the differences, in terms of visual outcome and treatment needs, between smokers and non-smokers central serous chorioretinopathy (CSCR) patients. Methods: The files of 252 patients diagnosed with CSCR who had presented to the Retina Unit of the Ophthalmology Clinic at Dicle University Medical School in Turkey were retrospectively evaluated. Eighty-four smokers, with a known history of smoking of at least one pack-year, and 133 non-smokers were included, whereas 35 patients with additional pathologies were excluded from the study. Results: Of the patients, 192 (88.5%) were male and 25 (11.5%) were female. The mean patient age was 38.8 ± 8.1 years (range: 20-68 years). Visual acuity (VA) of the smoker and non-smoker groups was measured as 0.45 ± 0.35 and 0.24 ± 0.28 logarithm of the minimum angle of resolution (logMar), respectively, at the first visit; 0.19 ± 0.29 and 0.06 ± 0.14 logMar at the sixth month; and 0.07 ± 0.14 and 0.02 ± 0.05 logMar at the ninth month. VA measurements at presentation and during all examinations (1th, 6th and 9th month) were significantly different for the two groups. VA was lower in the smoker group. In 27 patients (12.4%), an additional treatment modality was needed. Of the 27 patients, only 8 (6%) were non-smokers, whereas 19 (22.6%) were smokers. There was no difference between groups in the recurrence rate during follow-up (p = 0.907); 14 (16.7%) smokers and 8 (19.0%) non-smokers experienced a recurrence. Conclusion: This study has shown that patients selected and who are current smokers have poorer vision and need longer treatment.
Authors:
Fatih Mehmet Türkcü; Harun Yüksel; Alparslan Sahin; Yasin Cinar; Kürşat Cingü; Seyhmus Arı; Muhammed Sahin; Suat Altındağ; Ihsan Caça
Related Documents :
16953109 - Chronic development of ischaemic mitral regurgitation during post-infarction remodelling.
10660189 - The quadrileaflet mitral valve: follow-up in rheumatic heart disease.
15597589 - Twenty-five years' clinical experience with repair of tricuspid insufficiency.
15013119 - Contemporary results of mitral valve repair for infective endocarditis.
10478809 - Long-term clinical and echocardiographic outcome in patients with mitral stenosis treat...
10750749 - Cosgrove-edwards annuloplasty system: midterm results.
17950209 - The natural history of untreated dorsal wrist ganglia and patient reported outcome 6 ye...
19506469 - Outcomes of vascular access creation prior to dialysis: building the case for early ref...
2028349 - Surgery for the wolff-parkinson-white syndrome. the groote schuur hospital experience.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-7-10
Journal Detail:
Title:  Cutaneous and ocular toxicology     Volume:  -     ISSN:  1556-9535     ISO Abbreviation:  Cutan Ocul Toxicol     Publication Date:  2013 Jul 
Date Detail:
Created Date:  2013-7-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101266892     Medline TA:  Cutan Ocul Toxicol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Ophthalmology, Dicle University Faculty of Medicine , Diyarbakir , Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Gender Differences in Natural Language Factors of Subjective Intoxication in College Students: An Ex...
Next Document:  Chemical mimicry of insect oviposition sites: a global analysis of convergence in angiosperms.